RT Journal Article
SR Electronic
T1 The Impact of Myosteatosis on Cardiac Function in a Healthy Population: Insights from Abdominal CT Imaging
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.02.24311439
DO 10.1101/2024.08.02.24311439
A1 Kim, Myung Jin
A1 Nam, Hyo-Jung
A1 Cho, Yun Kyung
A1 Kim, Eun Hee
A1 Lee, Min Jung
A1 Lee, Woo Je
A1 Kim, Hong-Kyu
A1 Jung, Chang Hee
YR 2024
UL http://medrxiv.org/content/early/2024/08/04/2024.08.02.24311439.abstract
AB Background: Ectopic fat deposition in skeletal muscle, termed myosteatosis, is a key factor in insulin resistance and contributes to various metabolic disturbances. This study evaluated the association between myosteatosis, assessed via abdominal computed tomography, and cardiac function in an asymptomatic Korean population.Methods: This cross-sectional study included 7,716 participants (4,902 [63.5%] men and 2,814 [36.5%] women, mean age 53.2 ± 8.0) who underwent routine health check-ups at Asan Medical Center (Seoul, Korea). Myosteatosis was evaluated by segmenting the total abdominal muscle area (TAMA) at the L3 vertebral level into normal-attenuation muscle area (NAMA), low-attenuation muscle area (LAMA), and inter-/intra-muscular adipose tissue (IMAT). Patients were categorized into quartiles based on the NAMA/TAMA index, calculated by dividing the NAMA by TAMA and multiplying by 100. Cardiac function was assessed by transthoracic echocardiography.Results: Higher NAMA/TAMA index levels were associated with decreased absolute values of the E/E’ ratio and increased E/A ratio in both men and women. Multiple linear regression analysis revealed a significant correlation between the NAMA/TAMA index and both the E/A and E/E’ ratios after adjusting for covariates. No significant correlation was found with left ventricular (LV) ejection fraction or LV mass index.Conclusions: The degree of myosteatosis was significantly associated with diastolic function in an asymptomatic population, while systolic function remained unaffected.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Institutional Review Board of Asan Medical Center (IRB No. 2023-1360).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the corresponding author, C.H.J., upon reasonable request.